Form D · Other Health Care

LARADA SCIENCES INC

Salt Lake City, UT · CIK 0001396156

Offering snapshot reported Mar 27, 2014 · SEC filing

Reported sold
$400K
Offering amount: $585K
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 11, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 27, 2014Initial$400,000No comparison2SEC filing
Aug 11, 2011Initial$400,469No comparison16SEC filing
Nov 2, 2010Amendment$1,828,880No comparison31SEC filing
Nov 1, 2010Amendment$1,828,880No comparison23SEC filing
Aug 10, 2009InitialYet to sellNo comparison18SEC filing
Jun 9, 2009Initial$300,000No comparison9SEC filing
Apr 9, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-214323

Source: Form D, filed Mar 27, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Randall D. Block Director, Executive
James Carlson Director
Dale Clayton Director, Executive
Gene Jones Director
Yuri Pikover Director
Larry D. Rigby Director, Executive
Claire Roberts Director, Executive
David Rudd Executive
Greg Schenk Director
Brent Sloan Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
350 West 800 North, Suite 203
Salt Lake City, UT, 84103